We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Integrated LC-MS Strategies for Drug Discovery and Clinical Bioanalysis

Integrated LC-MS drug discovery and clinical bioanalysis illustration with DNA helix, test tubes, and pipette.
Credit: iStock.

Pharmaceutical development groups frequently maintain entirely separate analytical pipelines, instruments, and software configurations to process small molecules and large biologics. An integrated liquid chromatography–mass spectrometry infrastructure allows a single laboratory to support both modalities from initial discovery through clinical trials.  


This eBook lays out complete integrated bioanalytical workflows designed to remove sample preparation bottlenecks and satisfy data integrity regulations.  


Download this eBook to see how:  

  • Unified separation systems process diverse sample types without requiring hardware reconfigurations 
  • High-resolution mass spectrometry captures both qualitative structural profiles and quantitative values simultaneously 
  • Compliance-ready software architectures streamline sample tracking and data reporting for regulatory submissions 
Brought to you by

Download the eBook for FREE Now!
Information you provide will be shared with the sponsors for this content. Technology Networks or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.